TGFB1 and neoplasm: We acknowledge that other microenvironmental cells, such as stromal cells, may play a role in treatment efficacy differences; however, the presence of myeloid cells and the efficacy observed with myeloid-targeting therapies suggest that myeloid cells are important in tumor persistence despite PD-1 and TGF-β inhibition.